CoChat

Chronic benzodiazepine administration

Open access

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

Clinical studies suggest that carbamazepine may attenuate effects of alprazolam discontinuation. Since discontinuation of chronic alprazolam in a mouse model is associated with behavioral alterations and upregulation at the gamma-aminobutyric acidA (GABAA) receptor, we studied the effects of carbamazepine administration after alprazolam (2 mg/kg/day) discontinuation. Open-field activity was increased in mice 4 days after alprazolam discontinuation, but this effect was reduced significantly by continuous infusion of carbamazepine, 25 or 100 mg/kg/day. Benzodiazepine receptor binding in vivo was increased in cortex at 2 and 4 days after alprazolam discontinuation, and in hypothalamus at 4 days; with carbamazepine, 100 mg/kg/day, binding in both regions at these time points was similar to control values. Similar results were observed in cortex with benzodiazepine receptor binding in vitro. GABA-dependent chloride uptake was also increased at 4 days alprazolam administration. Treatment with carbamazepine attenuated (P less than 0.10) this increase. Carbamazepine alone after vehicle did not alter benzodiazepine binding or GABA-dependent chloride uptake. These results indicate that carbamazepine administration after alprazolam discontinuation attenuates behavioral and neurochemical alterations associated with discontinuation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0006-2952(91)90398-o

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Effects of alprazolam discontinuation on open-field activity. Activity was determined over a 5min interval between 9:00 a.m. and 12:00 noon using a Digiscan apparatus. Results are means, N = 7– 11 for each group. SEM were less than 20% of means. ALP/VEH = alprazolam for 7 days followed by vehicle for 7 days; VEH/CBP = vehicle for 7 days followed by carbamazepine for 7 days; ALP/ CBP = alprazolam for 7 days followed by carbamazepine for 7 days; 100 = 100 mg/kg/day; 25 = 25 mg/ kg/day. Key: (*) P < 0.05 vs control.
Fig. 1 Effects of alprazolam discontinuation on open-field activity. Activity was determined over a 5min interval between 9:00 a.m. and 12:00 noon using a Digiscan apparatus. Results are means, N = 7– 11 for each group. SEM were less than 20% of means. ALP/VEH = alprazolam for 7 days followed by vehicle for 7 days; VEH/CBP = vehicle for 7 days followed by carbamazepine for 7 days; ALP/ CBP = alprazolam for 7 days followed by carbamazepine for 7 days; 100 = 100 mg/kg/day; 25 = 25 mg/ kg/day. Key: (*) P < 0.05 vs control.CC-BY-NC-ND · From the PDF
Fig. 2 Effects of alprazolam discontinuation on benzodiazepine binding in vivo. Binding was determined by uptake of [³H]Ro15-1788. Results are means ± SEM, N = 6-10 for each group. ALP/VEH = alprazolam for 7 days followed by vehicle for 7 days; VEH/ČBP = vehicle for 7 days followed by carbamazepine, 100 mg/kg/day, for 7 days; ALP/CBP = alprazolam for 7 days followed by carbamazepine for 7 days. Key: (*) P < 0.05 for ALP/ VEH at days 2 or 4 vs day 1.
Fig. 2 Effects of alprazolam discontinuation on benzodiazepine binding in vivo. Binding was determined by uptake of [³H]Ro15-1788. Results are means ± SEM, N = 6-10 for each group. ALP/VEH = alprazolam for 7 days followed by vehicle for 7 days; VEH/ČBP = vehicle for 7 days followed by carbamazepine, 100 mg/kg/day, for 7 days; ALP/CBP = alprazolam for 7 days followed by carbamazepine for 7 days. Key: (*) P < 0.05 for ALP/ VEH at days 2 or 4 vs day 1.CC-BY-NC-ND · From the PDF
Fig. 3 Effects of alprazolam discontinuation on GABAdependent chloride uptake in cortex. Uptake was determined in cortical synaptoneurosomes over a 6-sec interval. Results are means, N = 3–5 for each group. SEM were less than 20% of means. AL/VEH = alprazolam for 7 days followed by vehicle for 7 days; VEH/CBP = vehicle for 7 days followed by carbamazepine for 7 days; AL/ CBP = alprazolam for 7 days followed by carbamazepine for 7 days. As indicated in the bottom panel, uptake at 50 μM muscimol was significantly greater (* = P < 0.05). for AL/VEH at day 4 compared to day 1, and for AL/ VEH compared to VEH/CP at day 4. Uptake at 50 μ muscimol was not significantly different at day 4 for ÀL/ VEH and AL/CBP (P < 0.10).
Fig. 3 Effects of alprazolam discontinuation on GABAdependent chloride uptake in cortex. Uptake was determined in cortical synaptoneurosomes over a 6-sec interval. Results are means, N = 3–5 for each group. SEM were less than 20% of means. AL/VEH = alprazolam for 7 days followed by vehicle for 7 days; VEH/CBP = vehicle for 7 days followed by carbamazepine for 7 days; AL/ CBP = alprazolam for 7 days followed by carbamazepine for 7 days. As indicated in the bottom panel, uptake at 50 μM muscimol was significantly greater (* = P < 0.05). for AL/VEH at day 4 compared to day 1, and for AL/ VEH compared to VEH/CP at day 4. Uptake at 50 μ muscimol was not significantly different at day 4 for ÀL/ VEH and AL/CBP (P < 0.10).CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. MacDonald, 1988, Antiepileptic drug actions discussion, Epilepsia, S19

Cited by

See all 17

Metadata

Authors
Galpern, W. R., Miller, L. G., greenblatt, D. J., Szabo, G. K., Browne, T. R., & Shader, R. I.
Affiliations
  • Boston University (US)
  • Tufts University (US)
Corresponding author
Miller, Lawrence G.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
1991-12
Volume
42
Pages
S99-S104
ISSN
0006-2952 (ISSN-L)
OpenAlex
W1527089640
Cited by
17
References
50
Citations by year
2023: 1 · 2022: 1 · 2021: 1 · 2017: 1
FWCI
0.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Biochemical Pharmacology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service
  • National Institute on Aging (AG-01-006)
  • National Institute of Mental Health (MH 34223)
  • National Institute on Drug Abuse (DA05258)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
carbamazepine, alprazolam, benzodiazepine withdrawal, benzodiazepine discontinuation, benzodiazepine binding, open field behavior
MeSH terms
Alprazolam, Animals, Anxiety, Carbamazepine, Cerebral Cortex, Disease Models, Animal, Drug Administration Schedule, Drug Evaluation, Preclinical, Hippocampus, Hypothalamus, Male, Motor Activity, Receptors, GABA-A, Seizures, Substance Withdrawal Syndrome, Time Factors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic benzodiazepine administration. https://app.cochat.ai/papers/10.1016/0006-2952(91)90398-o
The paper
Galpern, W. R., Miller, L. G., greenblatt, D. J., Szabo, G. K., Browne, T. R., & Shader, R. I. (1991). Chronic benzodiazepine administration. Biochemical Pharmacology. https://doi.org/10.1016/0006-2952(91)90398-o

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.